Trials / Unknown
UnknownNCT04561154
Identifying Functional and Psycho-social Complaints After Hospitalization for SARS-CoV-2 Infection( COVID 19)- REPERCOV
Identifying Functional and Psycho-social Complaints After Hospitalization for Severe SARS-CoV-2 Infection (COVID19)- REPERCOV
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 134 (estimated)
- Sponsor
- Centre Hospitalier le Mans · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Since December 2019, China and then the rest of the world have been affected by the rapid spread of a new coronavirus infection called SARS-CoV-2 (severe acute respiratory syndrome coronavirus), the clinical expression of which is called Covid-19 (Coronavirus Disease 2019). It is estimated that around 20% of symptomatic patients will be severe enough to warrant hospitalization, of which around 5% will be in intensive care. Organ damage is multiple in Covid infection: respiratory, digestive, renal, neurological, cardiovascular due to the infection or its care. There is also a psychological and social impact of the infection or of the care that should be measured. In this context, investigator will assess the physical and psychological complaints of patients who have presented a severe form of SARS-CoV-2 infection. The final objective being to identify the needs to offer follow-up adapted to this emerging pathology.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | questionnaire | three months after hospitalization, a questionnaire will be sent to patients. If necessary, patient will be seen in consultation of geriatry, otorhinolaryngology, pneumology, neuropsychology |
Timeline
- Start date
- 2020-06-11
- Primary completion
- 2021-06-11
- Completion
- 2022-06-11
- First posted
- 2020-09-23
- Last updated
- 2022-03-09
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04561154. Inclusion in this directory is not an endorsement.